NM_002067.5:c.626A>G
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM1PM2PP2PP3_StrongPP5_Moderate
The NM_002067.5(GNA11):c.626A>G(p.Gln209Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_002067.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Alteration of p.Gln209 in GNAQ is a recurrent oncogenic hotspot reported in the cBioPortal and NCI Genomic Data Commons cancer databases. This variant is absent from large population studies as a germline finding (Genome Aggregation Database v2.1.1). To our knowledge, this variant has not been reported in association with capillary malformations (CM) before, but somatic mutations altering amino acid residue p.Gln209 have been described in congenital hemangioma (PMID: 27058448). Somatic mutations altering amino acid residue p.Arg183 are known to cause capillary malformations (PMID: 30870248, PMID: 26368330, PMID: 29174369). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.